Literature DB >> 17055413

A second vaccine revolution for the new epidemics of the 21st century.

Mark R Dyer1, Wolfgang A Renner, Martin F Bachmann.   

Abstract

Non-communicable, chronic diseases are currently the major cause of death and disability worldwide, and many of these maladies have reached epidemic proportions. According to the World Health Organization (WHO) these disorders, including cardiovascular and respiratory diseases, diabetes, obesity and cancer, now account for about half of the global disease burden as well as deaths worldwide. The WHO identifies comparatively few risk factors, namely smoking, alcohol abuse, obesity, high cholesterol and high blood pressure, as the cause of many of these chronic conditions. A new class of medicines, based on vaccine approaches, are now in clinical trials and hold significant promise to treat both risk factors and their associated chronic diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055413     DOI: 10.1016/j.drudis.2006.09.006

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  4 in total

Review 1.  [HPV vaccines. Prophylactic vaccines from virus-like particles].

Authors:  R Kirnbauer
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

2.  Glucagon-like peptide-1 cleavage product GLP-1(9-36) amide rescues synaptic plasticity and memory deficits in Alzheimer's disease model mice.

Authors:  Tao Ma; Xueliang Du; Joseph E Pick; Guangzhi Sui; Michael Brownlee; Eric Klann
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

Review 3.  Therapeutic Vaccines for Hypertension: a New Option for Clinical Practice.

Authors:  Hironori Nakagami; Ryuichi Morishita
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 4.592

4.  Targeting senescent cells: approaches, opportunities, challenges.

Authors:  Cayetano von Kobbe
Journal:  Aging (Albany NY)       Date:  2019-11-30       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.